Global Pharma recalls eye drops after FDA contamination warning
India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.
Drugs
Pharma
Drugs
Pharma
BioNTech to invest $43 million in new mRNA facility
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA
Drugs
Medical
Pharma
GSK Plc gets FDA nod to make oral drug for anaemic CKD patients
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease
Drugs
Health
Pharma
India’s annual budget boosts ‘ayurveda’ spend
India’s federal budgetary allocation to the so-called Ayush Ministry, which oversees traditional healing systems, has increased by 20 percent to INR3647cr.
Climate
Health
Uncategorized
Cleaner fuel for passenger jets in the works
Malaysian oil and gas major PETRONAS and the Sarawak Economic Development Corporation (SEDC) have inked a pact to develop technology for microalgae oil
Drugs
Medical
Pharma
Max Healthcare profit jumps 7%, to raise INR 42 billion in debt
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,
Health
Medical
Pharma
Junk food increase ovarian, brain cancer risk: UK study
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar
Climate
Health
WMO plans global greenhouse monitoring network
The WMO is working on a plan to gauge heat-trapping atmospheric pollutants on the planet by creating a network of ground-based stations.
Drugs
Medical
Pharma
12 African nations commit to end AIDS in children by 2030
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs
Health
Pharma
Stelis Biopharma to be pure play CDMO firm, may list ‘near term’
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.